Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancy

Zeitschrift für Kinderheilkunde - Tập 151 - Trang 170-173 - 1992
P. Picco1, L. Garibaldi2, M. Cotellessa3, M. Di Rocco1, C. Borrone1
1Second Paediatric Division, G. Gaslini Institute, Genoa, Italy
2Cardinal Glennon Children's Hospital, St. Louis University, St. Louis, USA
3First Paediatric Clinic, G. Gaslini Institute, Genoa, Italy

Tóm tắt

Corticosterone methyl oxidase type II (CMO II) deficiency is an uncommon cause of salt-wasting in infancy. We describe a boy who presented with recurrent dehydration and severe failure to thrive in the first 3 months of life, associated with mild hyponatraemia (serum Na+ 127–132 mEq/l) and hyperkalaemia (serum K+ 5.3–5.9 mEq/l). The diagnosis was suggested by an elevated plasma renin activity (PRA): serum aldosterone ratio, and subsequently confirmed by an elevated serum 18-hydroxycorticosterone: aldosterone ratio. Treatment with 9α-fluorohydroxycortisone normalized growth parameters and PRA levels. CMO II deficiency should be considered in infants with recurrent dehydration and failure to thrive, even when serum sodium and potassium levels are not strikingly abnormal.

Tài liệu tham khảo

Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC (1987) Cloning of cDNA encoding steroid 11β-hydroxylase (P-450c11). Proc Natl Acad Sci USA 84:7193–7197 Globerman H, Rosler A, Theodor R, New MI, White PC (1988) An inherited defect in aldosterone biosynthesis caused by mutation in or near the gene for 11 hydroxylase. N Engl J Med 319:1193–1197 Healy JK, Elliot AJ (1977) The effect of a natriuretic dose of angiotensin or a rabbit kidney composition. Clin Sci 38:727–739 Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BCF, Brust N (1985) The constant plasma hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyl oxidase type II activity in disorders with variable aldosterone production. J Clin Endocrinol Metab 60:225–228 Kater CE, Biglieri EG, Brust N, Chang B, Hirai J, Irony I (1989) Stimulation and suppression of the mineralcorticoid hormones in normal subjects and adrenocortical disorders. Endocr Rev 10:149–164 Mornet E, Dupont J, Vitek A, White PC (1985) Characterization of the two genes encoding human steroid 11β-hydroxylase (P450 11β) J Biol Chem 264:20961–20967 New MJ, Levine LS (1984) Congenital adrenal hyperplasia. Springer, Berlin Heidelberg New York Rosler A (1984) The natural history of salt wasting disorders of adrenal and renal origin. J Clin Endocrinol Metab 59:689–700 Rosler A, Robinowitz D, Theodor R, Ramirez LC, Ulick S (1977) The nature of the defect in a salt wasting disorder in Jews of Iran. J Clin Endocrinol Metab 44:279–291 Royer P, Lestradet H, deMenibus CH, Vermeil G (1961) Hypoaldosteronisme familial chronique a debut neonatal. Ann Pediatr (Paris) 8:133–138 Ulick S (1976)Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway. J Clin Endocrinol Metab 43:92–96 Veldhuis JD, Melby JC (1981)Isolated aldosterone deficiency in man: acquired and inborn errors in the biosynthesis or action of aldosterone. Endocrinol Rev 2:495–517 Zadik Z, Kahana L, Kaufman H, Benderly A, Hochberg Z (1984) Salt loss in hypertensive form of congenital adrenal hyperplasia (11-β-hydroxylase deficiency). J Clin Endocrinol Metab 58:384–387